Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.45 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27909970 | 0.98 | CYP19A1 (0.50) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL9569687 | 0.84 | KMT2A (0.59) | KMT2ALMNAMEN1 | |
| SCHEMBL231450 | 0.84 | CYP19A1 (0.53) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL2551013 | 0.83 | PRSS1 (0.50) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL23818361 | 0.82 | KMT2A (0.47) | ELANEHSD17B10MAPTALDH1A1KMT2A | |
| SCHEMBL43742 | 0.81 | KMT2A (0.61) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL153387 | 0.81 | CYP19A1 (0.55) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL25527343 | 0.81 | HSD17B10 (0.52) | ELANEHSD17B10KMT2AHTT | |
| SCHEMBL10575704 | 0.81 | PRSS1 (0.49) | CYP19A1ELANETDP1ATML3MBTL1 | |
| SCHEMBL7631432 | 0.79 | PRSS1 (0.55) | CYP19A1TDP1PRSS1PRSS2PRSS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1747 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | CHORDA PHARMA INC (US) | 2026-04-30 | — | — | US | claimed |
| US-20250228759-A1 | ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN | SEASPIRE INC (US) | 2025-07-17 | — | — | US | claimed |
| WO-2023078310-A1 | NUTRIENT SOLUTION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 长春圣博玛生物材料有限公司 | 2023-05-11 | — | — | WO | claimed |
| CN-116077358-A | Nutrient solution and preparation method and application thereof | 长春圣博玛生物材料有限公司 | 2023-05-09 | — | — | CN | claimed |
| WO-2023009502-A1 | ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN | SEASPIRE, INC. (US) | 2023-02-02 | — | — | WO | claimed |
| US-10219994-B2 | Method for the simultaneous permanent shaping and dyeing of keratinic fibers | HENKEL AG & CO. KGAA (DE) | 2019-03-05 | — | — | US | claimed |
| US-9943477-B2 | Emulsion compositions containing a novel preservative system | L'OREAL (FR) | 2018-04-17 | — | — | US | claimed |
| US-20180015060-A1 | HEALING TOPICAL COMPOSITION | FLORENGALE, LLC | 2018-01-18 | — | — | US | claimed |
| EP-3250196-A1 | HEALING TOPICAL COMPOSITION | Florengale, LLC (US) | 2017-12-06 | — | — | EP | claimed |
| EP-2361079-B1 | METHOD FOR DYEING AND SHAPING KERATIN FIBERS | HENKEL AG & CO KGAA (DE) | 2017-05-31 | — | — | EP | claimed |
| US-20050238681-A1 | Storage-stable compositions of glycerol monoalkyl ethers | SCHULKE & MAYR GMBH (DE) | 2005-10-27 | — | — | US | claimed |
| US-20030149097-A1 | Storage-stable compositions of glycerol monoalkyl ethers | ASHLAND SPECIALTIES DEUTSCHLAND GMBH (DE) | 2003-08-07 | — | — | US | claimed |
| EP-1301168-A1 | STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS | Air Liquide Santé (International) (FR) | 2003-04-16 | — | — | EP | claimed |
| WO-2001093825-A1 | STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS | AIR LIQUIDE SANTE (INTERNATIONAL) (FR) | 2001-12-13 | — | — | WO | claimed |
| JP-2000512663-A | — | — | 2000-09-26 | — | — | JP | claimed |
| EP-1003469-A2 | FRAGRANCE PRECURSORS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2000-05-31 | — | — | EP | claimed |
| US-5925366-A | PERMEATION/BINDING AGENT, THIO CROSSLINKING AGENT, AND CHELATE COMPOUND | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1999-07-20 | — | — | US | claimed |
| US-5785959-A | MIXTURE CONTAINING A PERMEATION/BINDING AGENT, A THIO CROSSLINKING AGENT, A CHELATING AGENT, WATER AND AN OIL | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-07-28 | — | — | US | claimed |
| WO-1998006376-A1 | NAIL STRENGTHENING COMPOSITIONS AND A METHOD FOR STRENGTHENING NAILS | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-02-19 | — | — | WO | claimed |
| WO-1997030687-A2 | FRAGRANCE PRECURSORS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1997-08-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180015060-A1 | HEALING TOPICAL COMPOSITION | CUTA, CSDE1, SRI | CYP19A1 2488/4885ELANE 1760/4885TDP1 1330/4885 |
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | TRPV1, SPTLC3, FFAR3 | CYP19A1 2204/4885ELANE 4050/4885TDP1 1096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.